Resmed (RMD) CFO Sandercock sells $224k in stock holdings

Resmed (RMD) CFO, David Sandercock, sold $224,000 worth of company stock. This transaction includes a significant number of shares sold at a specific price per share, which was not disclosed in the article. Insider sales such as this may raise concerns among investors about the company's future performance. Monitoring executive transactions can provide insights into management's confidence regarding the company's outlook.